JAK2 and lung carcinoma: IL-6/JAK2/STAT3pathway enhances the occurrence of cancer and the proliferation of lung cancer stem cells (CSCs) by downregulating p53 and p21, which are cell cycle regulators caused by DNA hypermethylation, and upregulating DNMT1 (153).